InsiderTrades.com logo

OCUP Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 8.70%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Ocuphire Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at Ocuphire Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Ocuphire Pharma Share Price & Price History

Current Price: $0.00
Price Change: +0.30 (1.20%)
As of 10/23/2024 01:00 AM ET

This chart shows the closing price history over time for OCUP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Ocuphire Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/22/2024Ashwath JayagopalInsiderBuy3,500$1.76$6,160.0078,500View SEC Filing Icon  
3/21/2024Joseph K SchachleCOOBuy2,000$2.05$4,100.002,000View SEC Filing Icon  
3/21/2024Nirav S JhaveriCFOBuy10,000$2.10$21,000.00150,000View SEC Filing Icon  
3/18/2024George MagrathCEOBuy25,000$1.96$49,000.00425,000View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Ocuphire Pharma (NASDAQ:OCUP)

14.97% of Ocuphire Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at OCUP by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Ocuphire Pharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/12/2024Richmond Brothers Inc.191,304$0.29M0.6%-15.9%0.738%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC41,700$64K0.0%-69.2%0.161%Search for SEC Filing on Google Icon
8/8/2024Rice Hall James & Associates LLC223,589$0.34M0.0%-23.4%0.863%Search for SEC Filing on Google Icon
5/20/2024Virtu Financial LLC17,752$36K0.0%N/A0.068%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.992,200$1.99M0.0%+6.9%3.874%Search for SEC Filing on Google Icon
5/10/2024Richmond Brothers Inc.227,461$0.46M0.8%-10.0%0.888%Search for SEC Filing on Google Icon
5/7/2024Empowered Funds LLC36,605$74K0.0%N/A0.143%Search for SEC Filing on Google Icon
4/23/2024Rice Hall James & Associates LLC291,985$0.59M0.0%-48.9%1.177%Search for SEC Filing on Google Icon
2/8/2024Richmond Brothers Inc.252,769$0.76M1.3%-31.3%1.117%Search for SEC Filing on Google Icon
2/5/2024Victory Capital Management Inc.46,916$0.14M0.0%N/A0.207%Search for SEC Filing on Google Icon
2/5/2024Kestra Private Wealth Services LLC42,341$0.13M0.0%+323.4%0.187%Search for SEC Filing on Google Icon
11/13/2023Acadian Asset Management LLC49,563$0.17M0.0%+75.5%0.236%Search for SEC Filing on Google Icon
11/3/2023Richmond Brothers Inc.368,003$1.23M2.3%+7.6%1.752%Search for SEC Filing on Google Icon
11/2/2023Rice Hall James & Associates LLC828,628$2.78M0.2%-2.4%3.944%Search for SEC Filing on Google Icon
10/24/2023Stratos Wealth Partners LTD.23,925$80K0.0%-51.4%0.114%Search for SEC Filing on Google Icon
10/12/2023Legato Capital Management LLC10,098$34K0.0%-38.6%0.048%Search for SEC Filing on Google Icon
9/8/2023Tucker Asset Management LLC29,106$0.13M0.0%N/A0.139%Search for SEC Filing on Google Icon
8/11/2023O Shaughnessy Asset Management LLC11,525$50K0.0%N/A0.055%Search for SEC Filing on Google Icon
8/10/2023Private Advisor Group LLC10,200$44K0.0%-49.0%0.049%Search for SEC Filing on Google Icon
8/7/2023Acadian Asset Management LLC28,245$0.12M0.0%N/A0.135%Search for SEC Filing on Google Icon
8/2/2023MAI Capital Management485,048$2.11M0.0%-1.9%2.315%Search for SEC Filing on Google Icon
7/24/2023Rice Hall James & Associates LLC849,286$3.69M0.2%+5.0%4.054%Search for SEC Filing on Google Icon
7/18/2023Stratos Wealth Partners LTD.49,195$0.21M0.0%N/A0.235%Search for SEC Filing on Google Icon
7/13/2023Thompson Davis & CO. Inc.18,188$79K0.1%N/A0.087%Search for SEC Filing on Google Icon
7/10/2023Trust Co. of Toledo NA OH32,399$0.14M0.0%+24.6%0.155%Search for SEC Filing on Google Icon
5/12/2023Rice Hall James & Associates LLC809,117$3.03M0.2%+0.4%3.863%Search for SEC Filing on Google Icon
5/10/2023Richmond Brothers Inc.340,526$1.28M2.2%+3.5%1.625%Search for SEC Filing on Google Icon
5/10/2023MAI Capital Management494,690$1.86M0.0%+12.4%2.361%Search for SEC Filing on Google Icon
4/4/2023Trust Co. of Toledo NA OH26,000$98K0.0%N/A0.124%Search for SEC Filing on Google Icon
2/9/2023MAI Capital Management440,071$1.55M0.0%+23.3%2.115%Search for SEC Filing on Google Icon
2/8/2023Lincoln National Corp11,600$41K0.0%N/A0.056%Search for SEC Filing on Google Icon
2/8/2023Richmond Brothers Inc.328,970$1.16M1.6%+2.7%1.581%Search for SEC Filing on Google Icon
2/1/2023Legato Capital Management LLC16,456$58K0.0%N/A0.079%Search for SEC Filing on Google Icon
1/27/2023Rice Hall James & Associates LLC806,067$2.85M0.2%+49.2%3.874%Search for SEC Filing on Google Icon
1/18/2023Private Advisor Group LLC20,000$71K0.0%N/A0.096%Search for SEC Filing on Google Icon
11/8/2022Bedel Financial Consulting Inc.15,000$31K0.0%N/A0.073%Search for SEC Filing on Google Icon
11/2/2022Richmond Brothers Inc.320,332$0.64M0.7%+3.0%1.557%Search for SEC Filing on Google Icon
11/1/2022Rice Hall James & Associates LLC540,348$1.09M0.1%+65.0%2.626%Search for SEC Filing on Google Icon
8/12/2022Richmond Brothers Inc.311,120$0.60M0.6%+149.8%1.607%Search for SEC Filing on Google Icon
8/11/2022Warberg Asset Management LLC24,200$46K0.0%N/A0.125%Search for SEC Filing on Google Icon
8/8/2022Rice Hall James & Associates LLC327,494$0.63M0.0%+125.8%1.691%Search for SEC Filing on Google Icon
7/19/2022Eidelman Virant Capital25,000$48K0.0%N/A0.129%Search for SEC Filing on Google Icon
5/9/2022Powell Investment Advisors LLC13,500$44K0.0%N/A0.070%Search for SEC Filing on Google Icon
5/5/2022MCF Advisors LLC9,499$31K0.0%N/A0.049%Search for SEC Filing on Google Icon
5/5/2022Richmond Brothers Inc.124,544$0.40M0.3%+67.4%0.647%Search for SEC Filing on Google Icon
4/18/2022Spire Wealth Management9,002$29K0.0%N/A0.047%Search for SEC Filing on Google Icon
2/14/2022Rice Hall James & Associates LLC132,433$0.49M0.0%N/A0.766%Search for SEC Filing on Google Icon
2/14/2022Diametric Capital LP89,442$0.33M0.3%N/A0.517%Search for SEC Filing on Google Icon
2/10/2022Richmond Brothers Inc.74,420$0.28M0.2%N/A0.430%Search for SEC Filing on Google Icon
2/4/2022Frontier Wealth Management LLC18,000$67K0.0%-28.0%0.104%Search for SEC Filing on Google Icon
8/16/2021State Street Corp54,573$0.29M0.0%N/A0.434%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.37,315$0.20M0.0%N/A0.297%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Ocuphire Pharma logo
Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. The company offers Phentolamine Ophthalmic Solution for reversal of mydriasis, as well as is in Phase III clinical trials for presbyopia and dim light or night vision disturbances. Its lead retinal product candidate is APX3330, a small-molecule inhibitor of reduction oxidation effector factor-1 protein that has completed Phase II clinical trial for the treatment of diabetic retinopathy. The company also develops APX2009 and APX2014 that are preclinical product candidates for retina indications. The company was founded in 2018 and is headquartered in Farmington Hills, Michigan.
Read More on Ocuphire Pharma

Today's Range

Now: N/A

50 Day Range

MA: $1.26
Low: $1.17
High: $1.46

52 Week Range

Now: N/A

Volume

676,700 shs

Average Volume

171,840 shs

Market Capitalization

$30.33 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.2

Who are the company insiders with the largest holdings of Ocuphire Pharma?

Ocuphire Pharma's top insider shareholders include:
  1. George Magrath (CEO)
  2. Nirav S Jhaveri (CFO)
  3. Ashwath Jayagopal (Insider)
  4. Joseph K Schachle (COO)
Learn More about top insider investors at Ocuphire Pharma.